FDA permits emergency use of flu drugs, diagnostic test

04/27/2009 | Reuters · Wall Street Journal, The

The FDA has signed emergency authorizations for unapproved uses of GlaxoSmithKline's Relenza, Roche Holding's Tamiflu and the rRT-PCR Swine Flu Panel diagnostic test in response to the public health emergency declared amid the swine flu outbreak. The swine flu strain reportedly has infected more than 40 people in the U.S.

View Full Article in:

Reuters · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care